Fineline Cube

Follow:
14467 Articles
CompanyDrug

AstraZeneca’s Strensiq Approved for Rare Disease Therapy under Greater Bay Area’s Drug Access Policy

CompanyDeals

Johnson & Johnson to Acquire Israeli Cardiovascular Device Maker V-Wave for Upfront USD 600 Million

Policy / Regulatory

China’s VBP Office Exposes Collusion Among Six Firms in Bromhexine Bidding Process

CompanyPolicy / Regulatory

US Congress Seeks FDA Action on China Military Hospital Trials and Biopharma Security

CompanyDrug

Jiangsu Hansoh Pharmaceutical and GSK Win FDA Breakthrough Therapy Designation for B7-H3 Targeted ADC in Small-Cell Lung Cancer

CompanyDeals

Shanghai Henlius Biotech Secures Exclusive Rights to Convalife Pharmaceuticals’ Generic Neratinib in China

Company

WuXi XDC Accelerates Bioconjugate Drug Development with 67.6% YOY Revenue Increase in H1 2024

CompanyDeals

Finland’s Bone Index Partners with Lynx Financial for APAC and North American Market Expansion

Company

Chengdu Kanghua Biological Products Soars with 16.81% YOY Revenue Growth in H1 2024 Report

CompanyDrug

Johnson & Johnson’s Rybrevant-Lazclude Combo Approved by FDA for First-Line NSCLC Treatment

Company

CSPC Pharmaceutical Group Reports Modest Gains in H1 2024 with Patent Medicines Driving Revenue

CompanyDrug

AstraZeneca’s Strensiq Gains Approval for Rare Disease Therapy in Guangdong Under “Hong Kong-Macau Drug and Device Access”